Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Generation Bio Co. (GBIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.92+0.29 (+3.80%)
At close: 04:00PM EDT
7.53 -0.39 (-4.92%)
After hours: 05:33PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close7.63
Open7.50
Bid6.80 x 2200
Ask9.63 x 1800
Day's Range7.50 - 8.22
52 Week Range3.96 - 28.67
Volume211,020
Avg. Volume373,088
Market Cap450.726M
Beta (5Y Monthly)2.12
PE Ratio (TTM)N/A
EPS (TTM)-2.10
Earnings DateMar 16, 2022 - Mar 21, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est22.50
  • Zacks

    Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates

    Generation Bio Co. (GBIO) delivered earnings and revenue surprises of -4.76% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results

    Cash balance of $312.2M expected to fund operations into 2025CAMBRIDGE, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported business highlights and second quarter 2022 financial results. “We are advancing our leading non-viral genetic medicine platform to unlock the potential of durable, redosable non-viral DNA therapeutics, and we have made significant progre

  • GlobeNewswire

    Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference

    CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that the company will participate in a panel at the virtual 2022 Wedbush PacGrow Healthcare Conference on Tuesday, August 9th at 9:45 a.m. ET. A live webcast of the presentation will be available on the investor section of the company’s website at investors.generationbio.com. A replay will be avai

Advertisement
Advertisement